Daily Briefing: Singapore Medical Group buys stake in Australian clinic; Singtel price approaches 52-week low

And here are the four cheapest condo launches right now.

From Deal Street Asia:

Singapore Medical Group Ltd and South Korea’s CHA Healthcare Co Ltd have together bought a majority stake in Australia’s fourth-largest fertility clinic operator, City Fertility Centre.

CHA said in a regulatory filing it paid A$22.1m ($17.8m) for a 52% stake in the company, valuing City Fertility at A$42.5m.

Singapore Medical did not disclose a purchase price for the 13% stake it bought. Falling fertility rates across the region is spurring growth and deal-making in the in-vitro fertilisation (IVF) industry.

Read more here.

From The Motley Fool:

Singapore Telecommunications Limited (SGX: Z74) is Singapore’s largest operational telco.

At the current price of $3.52, the company’s stock is just a hair’s breadth higher than a 52-week low of $3.51. This captured my attention and got me interested in finding out whether Singtel has a quality business.

This question is important. If Singtel has a high quality business, its current low stock price could be an investment opportunity. Unfortunately, there’s no easy answer to the question. But, a simple metric can help shed some light on the question: The return on invested capital (ROIC).

Read more here.

From DollarsAndSense.sg:

Jointly developed by Hoi Hup Realty Pte Ltd and Sunway Developments, this roughly 635-unit condominium is situated in Anchorvale Lane in Sengkang. This land parcel drew bids from a whooping 16 developers. For context, tenders usually draws less than 10 developers making offers. It was sold for $240.95m.

Sitting on a 17,196 sqm site, the planned development is expected to consist of ten blocks of sixteen floors, with units ranging from three to five bedrooms. The indicative selling price of the units are estimated to be about $820 psf for this 99-years leasehold property.

Read more here.